Watertown, Mass. — November 24, 2025 — Leads & Copy — Kymera Therapeutics Inc. (NASDAQ: KYMR) will participate in fireside chats at three upcoming investor events in December, the company said today.
Kymera will present at the Piper Sandler 37th Annual Healthcare Conference in New York on December 2 at 2:30 p.m. Eastern time.
The company will also present at the Citi 2025 Global Healthcare Conference in Miami, Florida, on December 3 at 11:15 a.m. Eastern time and at the Evercore 8th Annual Healthcare Conference in Coral Gables, Florida, on December 4 at 8:45 a.m. Eastern time.
Kymera Therapeutics, based in Watertown, Massachusetts, is a clinical-stage biotechnology company focused on targeted protein degradation (TPD) to develop medicines. Its lead product is an oral small molecule degrader medicines for immunological diseases. Kymera is working to develop therapies for disease targets and pathways that are inaccessible with conventional therapeutics.
Live webcasts of the presentations will be available in the Investors section of the company’s website. Replays of the webcasts will be archived and available following the events.
Justine Koenigsberg, Vice President of Investor Relations, can be reached at investors@kymeratx.com, media@kymeratx.com, or 857-285-5300.
Source: Kymera Therapeutics, Inc.
